Hypoglycemia

Hypoglycemia, characterized by low plasma glucose levels, can cause both

sympathetic nervous system stimulation (e.g., sweating, palpitations) and
central nervous system dysfunction (e.g., confusion, seizures). It is a common
complication of diabetes treatment, especially with insulin or sulfonylureas
(e.g., glyburide, glipizide, glimepiride), but can also occur in non-diabetic
patients under certain conditions.

Etiology:
Hypoglycemia in non-diabetic patients can be insulin-mediated or non-insulin–
mediated. Common insulin-mediated causes include:

Exogenous insulin (in non-diabetic patients)

Insulin secretagogues (e.g., sulfonylureas)

Insulinoma (rare tumor producing insulin)

Post-bariatric surgery hypoglycemia (especially after roux-en-Y gastric

bypass)

Non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS)

Insulin autoimmune hypoglycemia (often linked to autoimmune diseases

like lupus)

Non-insulin–mediated causes include:

Adrenal insufficiency

Undernutrition, starvation, or cirrhosis

Sepsis or end-stage organ failure (liver, kidney, heart)

Non-islet cell tumor hypoglycemia (due to insulin-like growth factor

production by tumors)

Medications (e.g., quinine, alcohol)

Symptoms:
Autonomic symptoms (sweating, nausea, palpitations, anxiety) are often
followed by central nervous system symptoms (headache, confusion, seizures)
due to insufficient glucose supply to the brain. In patients with long-standing

Hypoglycemia 1
 diabetes, hypoglycemia unawareness may occur, where autonomic symptoms
are no longer felt.

Diagnosis:
For those on diabetes treatment, hypoglycemia is confirmed with a blood
glucose level below 70 mg/dL. For non-diabetic patients, diagnosis
follows Whipple's triad:

1. Symptoms of hypoglycemia

2. Low plasma glucose (<55 mg/dL) at the time of symptoms

3. Relief of symptoms after glucose administration

A 72-hour fast in a controlled setting is often required for diagnosing insulin-

mediated hypoglycemia. Testing involves measuring glucose, insulin, C-
peptide, and proinsulin to differentiate between exogenous (factitious) and
endogenous causes. If a patient experiences no symptoms after 72 hours,
insulinoma is usually excluded.

he surge in autonomic activity in response to low plasma glucose causes

sweating, nausea, warmth, anxiety, tremulousness, palpitations, and possibly
hunger and paresthesias. Insufficient glucose supply to the brain causes
headache, blurred or double vision, confusion, agitation, seizures, and coma. In
older patients, hypoglycemia may cause stroke-like symptoms of aphasia or
hemiparesis and is more likely to precipitate stroke, myocardial infarction, and
sudden death.

Patients with diabetes mellitus, especially patients with type 1 diabetes, type 2
diabetes of long duration or patients with frequent hypoglycemia may be
unaware of hypoglycemic episodes because they no longer experience
autonomic symptoms (hypoglycemia unawareness) (1).

In research studies under controlled conditions, autonomic symptoms begin at

or beneath a plasma glucose level of about 60 mg/dL (3.3 mmol/L), whereas
central nervous system symptoms occur at or below a glucose level of about
50 mg/dL (2.8 mmol/L) (2). People with glucose levels at these thresholds may
have no symptoms, while people with symptoms suggestive of hypoglycemia
can have normal glucose concentrations.

Hypoglycemia 2
 Certainly! Here's a more detailed explanation of the various complications of
diabetes mellitus (DM) and their pathophysiology:

Microvascular Disease in Diabetes Mellitus

Microvascular complications of diabetes primarily affect small blood vessels
and include diabetic retinopathy, diabetic nephropathy, and diabetic
neuropathy. These complications arise due to the effects of chronic
hyperglycemia on the vasculature, leading to endothelial dysfunction, altered
blood flow, and tissue damage.
Mechanisms of Vascular Disease in Diabetes:

1. Glycosylation of Serum and Tissue Proteins: High glucose levels lead to

nonenzymatic glycosylation of proteins, forming advanced glycation end-
products (AGEs). AGEs promote inflammation, oxidative stress, and
increased vascular permeability, all of which contribute to endothelial
dysfunction and the progression of vascular disease.

2. Superoxide Production: Hyperglycemia increases the production of

reactive oxygen species (ROS), leading to oxidative stress. This
exacerbates vascular inflammation and endothelial damage, contributing to
microvascular and macrovascular complications.

3. Activation of Protein Kinase C (PKC): PKC is a signaling molecule activated

by hyperglycemia. It promotes vascular permeability, endothelial
dysfunction, and angiogenesis, which can lead to conditions such as
retinopathy and nephropathy.

4. Hexosamine Pathway and Polyol Pathway Activation: Hyperglycemia

leads to the activation of the hexosamine pathway, contributing to tissue
fibrosis, and the polyol pathway, leading to the accumulation of sorbitol
within cells. Sorbitol accumulation causes osmotic stress, impairing nerve
function and contributing to neuropathy.

5. Hypertension and Dyslipidemia: Hypertension and dyslipidemia are

common in patients with diabetes and exacerbate vascular damage. They
can lead to the acceleration of atherosclerosis in both microvascular and
macrovascular vessels.

6. Proinflammatory and Prothrombotic Effects: Chronic hyperglycemia

results in a proinflammatory state, increasing the levels of prothrombotic

Hypoglycemia 3
 markers like fibrinogen, increasing platelet aggregation, and impairing the
ability of blood vessels to dilate and autoregulate.

Common Microvascular Complications:

1. Diabetic Retinopathy:

Background Retinopathy: Characterized by microaneurysms,

hemorrhages, and exudates due to leakage from small retinal vessels.

Proliferative Retinopathy: Neovascularization and vitreous

hemorrhages occur as a result of inadequate blood supply to the retina.

Macular Edema: Swelling in the macula due to fluid leakage, leading to

vision loss.

Treatment: Intensive glycemic and blood pressure control, laser

photocoagulation, and VEGF inhibitors like aflibercept, bevacizumab,
and ranibizumab.

2. Diabetic Nephropathy:

Pathophysiology: Thickening of the glomerular basement membrane,

mesangial expansion, and glomerulosclerosis lead to glomerular
hypertension and progressive decline in kidney function.

Clinical Manifestations: Initially asymptomatic, but later progresses to

nephrotic syndrome or kidney failure.

Diagnosis: Detection of urinary albumin (albumin:creatinine ratio) and a

decline in GFR.

Treatment: Strict glycemic control, blood pressure management, ACE

inhibitors or ARBs for albuminuria, and SGLT2 inhibitors in advanced
stages.

3. Diabetic Neuropathy:

Symmetric Polyneuropathy: Most common form, affecting distal limbs

(stocking-glove distribution). Symptoms include numbness, tingling,
pain, and loss of sensation.

Autonomic Neuropathy: Affects autonomic functions, leading to

problems like orthostatic hypotension, tachycardia, gastroparesis, and
erectile dysfunction.

Hypoglycemia 4
 Diagnosis: Detection of sensory deficits and reduced ankle reflexes.
Monofilament testing or tuning fork assessment may be used for foot
screening.

Treatment: Strict glycemic control, foot care, and medications to

manage symptoms (e.g., capsaicin, antidepressants, antiseizure drugs).

Macrovascular Disease in Diabetes Mellitus

Macrovascular complications result from atherosclerosis and are a major cause
of cardiovascular morbidity and mortality in diabetes. These complications
affect large blood vessels and include coronary artery
disease, cerebrovascular disease, and peripheral arterial disease.

Pathophysiology:

Atherosclerosis: Chronic hyperglycemia and insulin resistance promote

atherosclerosis by increasing lipoprotein oxidation, endothelial dysfunction,
and inflammation, leading to plaque formation in large arteries.

Hypertension and Dyslipidemia: Common comorbidities in diabetes that

accelerate atherosclerosis and increase the risk of cardiovascular events.

Clinical Manifestations:

1. Coronary Artery Disease (CAD):

Leads to angina pectoris and myocardial infarction due to narrowing

of the coronary arteries from atherosclerotic plaques.

2. Cerebrovascular Disease:

Includes transient ischemic attacks (TIA) and strokes due to impaired

blood flow to the brain.

3. Peripheral Arterial Disease (PAD):

Results in poor circulation, particularly in the lower extremities, leading

to ulcers, gangrene, and amputations in severe cases.

Treatment: Aggressive management of blood glucose, blood pressure, and

lipid levels, along with lifestyle changes (diet, exercise) and medications
(aspirin, statins). For cardiovascular protection, medications like metformin,
GLP-1 receptor agonists, and SGLT2 inhibitors are beneficial.

Other Complications of Diabetes Mellitus

Hypoglycemia 5
 1. Infection:

Patients with poorly controlled diabetes are more susceptible to

infections due to impaired immune response. Common infections
include bacterial skin infections, fungal infections (e.g., candidiasis),
and urinary tract infections.

Diabetic foot infections, including osteomyelitis, are frequent,

especially with peripheral neuropathy and vascular insufficiency.

2. Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD):

Also known as nonalcoholic fatty liver disease (NAFLD), it is a

common comorbidity of type 2 diabetes, with over half of diabetic
patients affected.

It results from insulin resistance and leads to hepatic steatosis (fat

accumulation in the liver). This can progress to metabolic dysfunction-
associated steatohepatitis (MASH), fibrosis, cirrhosis, and liver failure.

Treatment: Weight loss, use of medications like GLP-1 receptor

agonists (liraglutide, semaglutide), and pioglitazone have been shown
to reduce liver inflammation and slow progression.

3. Musculoskeletal Disorders:

Diabetes increases the risk of certain musculoskeletal problems such

as Dupuytren's contracture, adhesive capsulitis, and carpal tunnel
syndrome.

Charcot arthropathy, a joint disorder caused by neuropathy and

trauma, is a severe complication of diabetic neuropathy.

4. Ophthalmologic Conditions: Apart from diabetic retinopathy, patients are at

higher risk for other ocular problems like cataracts, glaucoma, and optic
neuropathy.

5. Neurological Complications:

Cognitive decline and dementia are more common in individuals with

diabetes, potentially due to the effects of hyperglycemia and vascular
disease on the brain.

6. Cardiomyopathy:

Diabetic cardiomyopathy is characterized by structural and functional

abnormalities in the heart, leading to heart failure. It is caused by a

Hypoglycemia 6
 combination of atherosclerosis, hypertension, microvascular disease,
and metabolic disturbances.

7. Depression:

Depression is more prevalent in individuals with diabetes and can

negatively affect diabetes management. The pathophysiology may
involve shared pathways related to inflammation, insulin resistance, and
neurohormonal dysfunction.

Prevention and Management of Complications

1. Glycemic Control: Intensive control of blood glucose can prevent or delay
the onset of microvascular complications. However, its impact on
macrovascular disease is less clear, particularly in type 2 diabetes.

2. Blood Pressure and Lipid Control: Management of hypertension and

dyslipidemia is essential to reduce the risk of cardiovascular events.

3. Lifestyle Modifications: A balanced diet, regular physical activity, and

weight management are crucial in reducing the risk of complications.

4. Regular Screening: Routine screening for diabetic retinopathy,

nephropathy, and neuropathy is essential for early detection and
intervention.

Hypoglycemia 7